Intraperitoneal Chemotherapy as Adjuvant or Perioperative Chemotherapy for Patients with Type 4 Scirrhous Gastric Cancer: PHOENIX-GC2 Trial

The prognosis of patients with type 4 scirrhous gastric cancer remains poor due to a high risk of peritoneal metastasis. We have previously developed combined chemotherapy regimens of intraperitoneal (IP) paclitaxel (PTX) and systemic chemotherapy, and promising clinical efficacy was reported in gas...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishigami, Hironori, Tsuji, Yasushi, Shinohara, Hisashi, Kodera, Yasuhiro, Kanda, Mitsuro, Yabusaki, Hiroshi, Ito, Seiji, Imano, Motohiro, Yamashita, Hiroharu, Hidemura, Akio, Yamaguchi, Hironori, Fukagawa, Takeo, Oba, Koji, Kitayama, Joji, Seto, Yasuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658657/
https://www.ncbi.nlm.nih.gov/pubmed/34884367
http://dx.doi.org/10.3390/jcm10235666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658657/
https://www.ncbi.nlm.nih.gov/pubmed/34884367
http://dx.doi.org/10.3390/jcm10235666

Ejemplares similares